The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma.
 
Kenneth F. Grossmann
No Relationships to Disclose
 
Megan Othus
No Relationships to Disclose
 
Sapna Pradyuman Patel
No Relationships to Disclose
 
Ahmad A. Tarhini
No Relationships to Disclose
 
Vernon K. Sondak
No Relationships to Disclose
 
Teresa M. Petrella
No Relationships to Disclose
 
Thach-Giao Truong
No Relationships to Disclose
 
Nikhil I. Khushalani
No Relationships to Disclose
 
Justine Vanessa Cohen
No Relationships to Disclose
 
Elizabeth Iannotti Buchbinder
No Relationships to Disclose
 
Kari Lynn Kendra
No Relationships to Disclose
 
Pauline Funchain
No Relationships to Disclose
 
Karl D. Lewis
No Relationships to Disclose
 
Bartosz Chmielowski
No Relationships to Disclose
 
Hongli Li
No Relationships to Disclose
 
James Moon
No Relationships to Disclose
 
Krishna Soujanya Gunturu
No Relationships to Disclose
 
Zeynep Eroglu
No Relationships to Disclose
 
John M. Kirkwood
No Relationships to Disclose
 
Antoni Ribas
No Relationships to Disclose